Beam Therapeutics Inc (NASDAQ:BEAM)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BEAM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BEAM

  • Market Cap$1.798bn
  • SymbolNASDAQ:BEAM
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS07373V1052

Company Profile

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises of Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Latest BEAM news

Currently there for this company. Visit our news hub for other news .